Biotensegrity of the Extracellular Matrix: Physiology, Dynamic Mechanical Balance, and Implications in Oncology and Mechanotherapy
NAGIOS: RODERIC FUNCIONANDO

Biotensegrity of the Extracellular Matrix: Physiology, Dynamic Mechanical Balance, and Implications in Oncology and Mechanotherapy

DSpace Repository

Biotensegrity of the Extracellular Matrix: Physiology, Dynamic Mechanical Balance, and Implications in Oncology and Mechanotherapy

Show simple item record

dc.contributor.author Tadeo Cervera, Irene es_ES
dc.contributor.author Berbegall Beltrán, Ana Pilar es_ES
dc.contributor.author Escudero, Luis M. es_ES
dc.contributor.author Álvaro Naranjo, Tomás es_ES
dc.contributor.author Noguera Salvá, Rosa es_ES
dc.date.accessioned 2015-06-18T07:02:04Z
dc.date.available 2015-06-18T07:02:04Z
dc.date.issued 2014 es_ES
dc.identifier.uri http://hdl.handle.net/10550/44420
dc.description.abstract Cells have the capacity to convert mechanical stimuli into chemical changes. This process is based on the tensegrity principle, a mechanism of tensional integrity. To date, this principle has been demonstrated to act in physiological processes such as mechanotransduction and mechanosensing at different scales (from cell sensing through integrins to molecular mechanical interventions or even localized massage). The process involves intra- and extracellular components, including the participation of extracellular matrix (ECM) and microtubules that act as compression structures, and actin filaments which act as tension structures. The nucleus itself has its own tensegrity system which is implicated in cell proliferation, differentiation, and apoptosis. Despite present advances, only the tip of the iceberg has so far been uncovered regarding the role of ECM compounds in influencing biotensegrity in pathological processes. Groups of cells, together with the surrounding ground substance, are subject to different and specific forces that certainly influence biological processes. In this paper, we review the current knowledge on the role of ECM elements in determining biotensegrity in malignant processes and describe their implication in therapeutic response, resistance to chemo- and radiotherapy, and subsequent tumor progression. Original data based on the study of neuroblastic tumors will be provided. es_ES
dc.source Frontiers in Oncology Vol. 4 es_ES
dc.subject biotensegrity es_ES
dc.subject cancer es_ES
dc.subject extracellular matrix es_ES
dc.subject mechanotherapy es_ES
dc.subject neuroblastoma es_ES
dc.title Biotensegrity of the Extracellular Matrix: Physiology, Dynamic Mechanical Balance, and Implications in Oncology and Mechanotherapy es_ES
dc.type info:eu-repo/semantics/article es_ES
dc.identifier.doi 10.3389/fonc.2014.00039 es_ES
dc.identifier.idgrec 100300 es_ES

View       (3.211Mb)

This item appears in the following Collection(s)

Show simple item record

Search DSpace

Advanced Search

Browse

Statistics